The effect of ethyl pyruvate and N-acetylcysteine on ischemia-reperfusion injury in an experimental model of ischemic stroke



      Reperfusion therapies play an important role in early-period treatment for patients presenting to the emergency department due to stroke. However, the ischemia-reperfusion injury that may occur with reperfusion must then be considered. The purpose of this study was to determine the effectiveness of N-acetylcysteine (NAC) and ethyl pyruvate in preventing ischemia-reperfusion injury.


      This study is a randomized, controlled experimental study. In group 1, rats' left main carotid arteries were clamped. Reperfusion was established by releasing the clamp after 1.5 hours. In group 2, the left main carotid artery was clamped, and 20 mg/kg intraperitoneal NAC was administered after 1 hour. The clamp was released 0.5 hour after NAC administration. In group 3, rats' left carotid arteries were clamped, and 50 mg/kg ethyl pyruvate was administered intraperitoneally after 1 hour. The clamp was released 0.5 hour after ethyl pyruvate administration. All tissue samples were collected 2.5 hours after reperfusion. Brain tissues were compared histopathologically.


      A higher percentage of degenerative neurons was determined in group 1 compared with groups 2 and 3 (P values: Pa = .003 and Pc = .003, respectively). A significant difference was also observed between groups 2 and 3 (Pb = .003), with the percentage of degenerative neurons being lower in the NAC group than in the ethyl pyruvate group.


      The use of NAC and ethyl pyruvate reduces injury resulting from ischemia-reperfusion in an experimental animal model of acute ischemic stroke and subsequent reperfusion.
      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bivard A
        • Lin L
        • Parsonsb MW
        Review of stroke thrombolytics.
        J Stroke. 2013; 15: 90-98
        • Fink MP
        Ethyl pyruvate.
        Curr Opin Anesthesiol. 2008; 21: 160-167
        • Abbasoğlu SD
        • Balkan J
        • Kanbağlı Ö
        • Çevikbas U
        • Toker GA
        • Uysal M
        Aminoguanidin ve N-asetilsisteinin endotoksemik sirozlu sıçanlarda karaciğer hasarı, oksidatif ve nitrozatif stres üzerine etkisi.
        Kocatepe Tıp Dergisi. 2004; 5: 27-32
        • Little JR
        Modification of acute ischemia by treatment with mannitol.
        Stroke. 1978; 9: 4-9
        • Garman RH
        Histology of the central nervous system.
        Toxicol Pathol. 2011; 39: 22-35
        • Jauch EC
        • Saver JL
        • Adams HP
        • Bruno A
        • Connors JJ
        • Demaerschalk BM
        • et al.
        Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2013; 44: 870-947
        • Saenger AK
        • Christenson RH
        Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation and treatment.
        Clin Chem. 2010; 56: 21-33
        • Kaçmaz A
        • Polat A
        • User Y
        • Tilki M
        • Ozkan S
        • Sener G
        Octreotide improves reperfusion-induced oxidative injury in acute abdominal hypertension in rats.
        J Gastrointest Surg. 2004; 8: 113-119
        • Zhang Z
        • Yan J
        • Taheri S
        • Liu KJ
        • Shi H
        Hypoxia-inducible factor 1 contributes to N-acetylcysteine's protection in stroke.
        Free Radic Biol Med. 2014; 68: 8-21
        • Oliveira Filho LD
        • Saad KR
        • Saad PF
        • Koike MK
        • Silva SM
        • Montero EF
        Effect of N-acetylcysteine in hearts of rats submitted to controlled hemorrhagic shock.
        Rev Bras Cir Cardiovasc. 2015; 30: 173-181
        • Yang R
        • Shaufl AL
        • Killeen ME
        • Fink MP
        Ethyl pyruvate ameliorates liver injury secondary to severe acute pancreatitis.
        J Surg Res. 2009; 153: 302-309
        • Price TO
        • Uras F
        • Banks WA
        • Ercal N
        A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat induced oxidative stress in brainendothelial cells.
        Exp Neurol. 2006; 201: 193-202
        • Gilgun-Sherki Y
        • Melamed E
        • Offen D
        Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier.
        Neuropharmacology. 2001; 40: 959-975
        • Saver JL
        • Starkman S
        • Eckstein M
        • Stratton SJ
        • Pratt FD
        • Hamilton S
        • et al.
        Prehospital use of magnesium sulfate as neuroprotection in acute stroke.
        N Engl J Med. 2015; 372: 528-536
        • Bederson JB
        • Connolly Jr., ES
        • Batjer HH
        • Dacey RG
        • Dion JE
        • Diringer MN
        • et al.
        Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council.
        Am Heart Assoc Stroke. 2009; 40: 994-1025
        • Wahlgren NG
        • MacMahon DG
        • DeKeyser J
        • Indredavik B
        • Ryman T
        Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke.
        Cerebrovasc Dis. 1994; 4: 204-210
        • Parmar S
        • Moore-Langston S
        • Fredrickson V
        • Kim JM
        • Rastogi R
        • Elmadoun O
        • et al.
        Neuroprotective mechanisms of oxygen and ethanol: a potential combination therapy in stroke.
        Curr Med Chem. 2015; 22: 1194-1204